Overview of the Global Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

In 2021, after five years of growth, there was decline in the global human and animal blood market, when its value decreased by -X% to $X. The market value increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. Global consumption peaked at $X in 2020, and then fell slightly in the following year.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

In value terms, human and animal blood production shrank modestly to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2018 when the production volume increased by X%. Global production peaked at $X in 2020, and then dropped modestly in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports

Global human and animal blood exports soared to X tons in 2021, with an increase of X% compared with 2020. Overall, total exports indicated a resilient increase from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, human and animal blood exports skyrocketed to $X in 2021. Over the period under review, exports saw a resilient expansion. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

The United States was the key exporter of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the world, with the volume of exports resulting at X tons, which was near X% of total exports in 2021. France (X tons) held the second position in the ranking, followed by Denmark (X tons), Canada (X tons), Germany (X tons) and the UK (X tons). All these countries together held near X% share of total exports. The Netherlands (X tons), Italy (X tons), Spain (X tons), Argentina (X tons) and India (X tons) followed a long way behind the leaders.

Exports from the United States increased at an average annual rate of +X% from 2012 to 2021. At the same time, India (+X%), the Netherlands (+X%), Italy (+X%), Spain (+X%), the UK (+X%), Canada (+X%), Denmark (+X%), Germany (+X%) and France (+X%) displayed positive paces of growth. Moreover, India emerged as the fastest-growing exporter exported in the world, with a CAGR of +X% from 2012-2021. By contrast, Argentina (-X%) illustrated a downward trend over the same period. The United States (+X p.p.), the Netherlands (+X p.p.), the UK (+X p.p.) and Italy (+X p.p.) significantly strengthened its position in terms of the global exports, while Germany, Denmark, Argentina and France saw its share reduced by -X%, -X%, -X% and -X% from 2012 to 2021, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the United States ($X) remains the largest human and animal blood supplier worldwide, comprising X% of global exports. The second position in the ranking was held by Germany ($X), with an X% share of global exports. It was followed by the UK, with a X% share.

In the United States, human and animal blood exports expanded at an average annual rate of +X% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Germany (+X% per year) and the UK (+X% per year).

Export Prices by Country

The average human and animal blood export price stood at $X per ton in 2021, with an increase of X% against the previous year. In general, export price indicated a strong expansion from 2012 to 2021: its price increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, human and animal blood export price increased by +X% against 2014 indices. The pace of growth was the most pronounced in 2017 when the average export price increased by X% against the previous year. The global export price peaked in 2021 and is likely to continue growth in years to come.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was Germany ($X per ton), while Argentina ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by France (+X%), while the other global leaders experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports

For the sixth consecutive year, the global market recorded growth in overseas purchases of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, which increased by X% to X tons in 2021. In general, imports showed a resilient expansion. As a result, imports reached the peak and are likely to continue growth in the immediate term.

In value terms, human and animal blood imports surged to $X in 2021. Over the period under review, total imports indicated a prominent expansion from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2013 indices. The pace of growth appeared the most rapid in 2017 when imports increased by X% against the previous year. Global imports peaked in 2021 and are expected to retain growth in the near future.

Imports by Country

In 2021, Canada (X tons), followed by France (X tons) and Germany (X tons) were the largest importers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, together creating X% of total imports. The following importers - the United States (X tons), the Netherlands (X tons), Nigeria (X tons), Denmark (X tons), Austria (X tons), China (X tons), Brazil (X tons), the UK (X tons), Belgium (X tons) and Spain (X tons) - each accounted for a X% share of total imports.

From 2012 to 2021, the biggest increases were in Nigeria (with a CAGR of +X%), while purchases for the other global leaders experienced more modest paces of growth.

In value terms, the largest human and animal blood importing markets worldwide were the United States ($X), Germany ($X) and France ($X), with a combined X% share of global imports. China, the UK, Canada, Belgium, Brazil, the Netherlands, Spain, Denmark, Nigeria and Austria lagged somewhat behind, together comprising a further X terms of the main importing countries, Nigeria, with a CAGR of +X%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the average human and animal blood import price amounted to $X per ton, falling by -X% against the previous year. Over the period under review, the import price showed a noticeable downturn. The most prominent rate of growth was recorded in 2018 an increase of X%. Over the period under review, average import prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2021, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was the United States ($X per ton), while Austria ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the UK (+X%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :